CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $109.49 billion. The enterprise value is $111.01 billion.
| Market Cap | 109.49B |
| Enterprise Value | 111.01B |
Important Dates
The last earnings date was Wednesday, October 21, 2026, before market open.
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | Sep 9, 2026 |
Share Statistics
CME Group has 357.93 million shares outstanding. The number of shares has increased by 0.16% in one year.
| Current Share Class | 357.93M |
| Shares Outstanding | 357.93M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | -0.73% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 91.02% |
| Float | 353.02M |
Valuation Ratios
The trailing PE ratio is 25.08 and the forward PE ratio is 23.63. CME Group's PEG ratio is 3.32.
| PE Ratio | 25.08 |
| Forward PE | 23.63 |
| PS Ratio | 15.74 |
| Forward PS | 14.97 |
| PB Ratio | 4.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.27 |
| P/OCF Ratio | 24.73 |
| PEG Ratio | 3.32 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.47, with an EV/FCF ratio of 25.62.
| EV / Earnings | 25.22 |
| EV / Sales | 15.96 |
| EV / EBITDA | 22.47 |
| EV / EBIT | 24.09 |
| EV / FCF | 25.62 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 0.89 |
| Interest Coverage | 26.42 |
Financial Efficiency
Return on equity (ROE) is 16.13% and return on invested capital (ROIC) is 12.55%.
| Return on Equity (ROE) | 16.13% |
| Return on Assets (ROA) | 1.52% |
| Return on Invested Capital (ROIC) | 12.55% |
| Return on Capital Employed (ROCE) | 12.81% |
| Weighted Average Cost of Capital (WACC) | 5.20% |
| Revenue Per Employee | $1.80M |
| Profits Per Employee | $1.14M |
| Employee Count | 3,875 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $1.36 billion in taxes.
| Income Tax | 1.36B |
| Effective Tax Rate | 23.49% |
Stock Price Statistics
The stock price has increased by +14.14% in the last 52 weeks. The beta is 0.18, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +14.14% |
| 50-Day Moving Average | 283.10 |
| 200-Day Moving Average | 280.89 |
| Relative Strength Index (RSI) | 64.12 |
| Average Volume (20 Days) | 2,056,102 |
Short Selling Information
The latest short interest is 4.99 million, so 1.39% of the outstanding shares have been sold short.
| Short Interest | 4.99M |
| Short Previous Month | 5.53M |
| Short % of Shares Out | 1.39% |
| Short % of Float | 1.41% |
| Short Ratio (days to cover) | 2.65 |
Income Statement
In the last 12 months, CME Group had revenue of $6.96 billion and earned $4.40 billion in profits. Earnings per share was $12.19.
| Revenue | 6.96B |
| Gross Profit | 6.96B |
| Operating Income | 4.61B |
| Pretax Income | 5.77B |
| Net Income | 4.40B |
| EBITDA | 4.94B |
| EBIT | 4.61B |
| Earnings Per Share (EPS) | $12.19 |
Balance Sheet
The company has $2.33 billion in cash and $3.85 billion in debt, with a net cash position of -$1.52 billion or -$4.26 per share.
| Cash & Cash Equivalents | 2.33B |
| Total Debt | 3.85B |
| Net Cash | -1.52B |
| Net Cash Per Share | -$4.26 |
| Equity (Book Value) | 26.56B |
| Book Value Per Share | 74.31 |
| Working Capital | 3.03B |
Cash Flow
In the last 12 months, operating cash flow was $4.43 billion and capital expenditures -$93.70 million, giving a free cash flow of $4.33 billion.
| Operating Cash Flow | 4.43B |
| Capital Expenditures | -93.70M |
| Depreciation & Amortization | 333.30M |
| Net Borrowing | n/a |
| Free Cash Flow | 4.33B |
| FCF Per Share | $12.11 |
Margins
Gross margin is 100.00%, with operating and profit margins of 66.24% and 63.48%.
| Gross Margin | 100.00% |
| Operating Margin | 66.24% |
| Pretax Margin | 82.97% |
| Profit Margin | 63.48% |
| EBITDA Margin | 71.03% |
| EBIT Margin | 66.24% |
| FCF Margin | 62.29% |
Dividends & Yields
This stock pays an annual dividend of $11.35, which amounts to a dividend yield of 3.71%.
| Dividend Per Share | $11.35 |
| Dividend Yield | 3.71% |
| Dividend Growth (YoY) | 5.61% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 92.66% |
| FCF Payout Ratio | 93.34% |
| Buyback Yield | -0.16% |
| Shareholder Yield | 3.56% |
| Earnings Yield | 3.99% |
| FCF Yield | 3.96% |
Analyst Forecast
The average price target for CME Group is $317.06, which is 3.65% higher than the current price. The consensus rating is "Buy".
| Price Target | $317.06 |
| Price Target Difference | 3.65% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 6.79% |
| EPS Growth Forecast (3Y) | 8.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.54 |
| Piotroski F-Score | 4 |